Tuberculosis In India: Understanding The Disease And The Road To Eradication
Tuberculosis (TB) poses a persistent challenge to public health in India, with ongoing efforts to combat the disease. This overview delves into the multifaceted landscape of TB, exploring its impact on public health, recent treatment advancements, detection methods, and the obstacles hindering the nation’s goal of eradication. Additionally, exploring the role of health insurance, mainly through providers like Bajaj Allianz, becomes pivotal in understanding how comprehensive healthcare coverage can contribute to the broader efforts to combat and eliminate TB.
India’s TB fight shows significant strides, with a 16% decline in incidence and an 18% drop in mortality rates since 2015, exceeding global trends. However, complete eradication by 2025 remains challenging, with recent reports highlighting urgent issues.
Challenges in Achieving Elimination
- Policy Adjustments Needed
Reports of drug shortages in some states, suboptimal TB detection practices, and the vital role of nutrition in preventing TB underscore policy issues hindering India’s path to eradication. The World Health Organisation (WHO) report disclosed a record 24.2 lakh patients notified in 2022, a significant increase from 15.6 lakh in 2014. While innovative policies, such as crowdsourcing initiatives and collaboration with the private sector, have contributed to success, challenges persist.
- Detection And Curative Capacities
Despite increased government funding, the uptake of sophisticated molecular diagnostics still needs to be improved. In 2022, 77% of suspected TB patients relied on smear microscopy, an inaccurate method. Shifting quickly to molecular diagnostics and reevaluating testing rates, which currently stand at 1.2%, is imperative. The information presented above is not meant to be a substitute for medical advice. Please consult a medical professional before undergoing any treatment/procedure that suits your health, age, and other aspects.
- Screening Methods And Innovative Technologies
Relying mainly on symptomatic screening poses a challenge, given that 46% of diagnosed cases were asymptomatic, as the national prevalence study revealed. Embracing portable AI-enabled X-ray applications could offer an efficient and affordable alternative. The information presented above is not meant to be a substitute for medical advice. Please consult a medical professional before undergoing any treatment/procedure that suits your health, age, and other aspects.
Addressing Drug Shortages And Treatment Adherence
Programmatic Success And Central-State Dynamics
While initiating treatment in all positive cases is a programmatic achievement, the shift of responsibilities to states may impact drug availability. Historically reliant on the federal government for pharmaceuticals and diagnostics, states now face challenges negotiating prices due to local restrictions and lower volume requirements.
Optimising Treatment Option
Ensuring treatment adherence is crucial, necessitating exploring better, less harmful treatment options. The WHO-recommended Bedaquiline, Pretomanid, Linezolid (BPaL(M) regimen for drug-resistant patients, boasting an efficacy of 85–90%, is a promising alternative. The information presented above is not meant to be a substitute for medical advice. Please consult a medical professional before undergoing any treatment/procedure that suits your health, age, and other aspects.
The Role of Vaccination In TB Eradication
Recognising the negligible impact without a vaccine, experts emphasise the necessity of a new TB vaccine, considering that the existing BCG vaccine may fall short. Developing a robust vaccine strategy is pivotal for achieving complete eradication. The information presented above is not meant to be a substitute for medical advice. Please consult a medical professional before undergoing any treatment/procedure that suits your health, age, and other aspects.
In navigating the path towards TB eradication in India, the role of health insurance emerges as a critical component. As exemplified by Bajaj Allianz health insurance plans for families, comprehensive coverage ensures access to quality healthcare and facilitates the financial resilience of individuals facing the challenges posed by TB. Claims are subject to terms and conditions set forth under the health insurance policy. *
The renewal of health insurance policies becomes a beacon of continuity in the fight against TB, providing a sustained shield for families and individuals. By synergising healthcare initiatives, strategic policy adjustments, and robust health insurance plans, India can forge a more resilient and effective front against tuberculosis, ultimately inching closer to the collective vision of a TB-free nation. Claims are subject to terms and conditions set forth under the health insurance policy. *
Subscribe to Bajaj Allianz General Insurance YouTube Channel here!
*Standard T&C Apply
Insurance is the subject matter of solicitation. For more details on benefits, exclusions, limitations, terms, and conditions, please read the sales brochure/policy wording carefully before concluding a sale.
